COMPANY PROFILE

Spirosure

Explore full profile

Startup company based in pleasanton, california, focusing on research, development

Pleasanton, United StatesFounded 2012Biotech & Life Sciences

Valuation $50–100M Last recorded · 2018

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Spirosure

Spirosure operates in the healthcare technology sector, focusing on the development and commercialization of advanced diagnostic tools for respiratory diseases. The company's flagship product is the Fenom System, a point-of-care breath analyzer that measures Fractional Exhaled Nitric Oxide (FeNO) levels. This technology aids healthcare professionals in accurately assessing airway inflammation, which is crucial for managing chronic pulmonary conditions such as asthma, COPD, cystic fibrosis, and pulmonary hypertension. By providing precise measurements, the Fenom System helps in titrating medications and adjusting treatments to reduce exacerbations, ultimately improving patient outcomes. Spirosure primarily serves healthcare providers, including hospitals and clinics, who require reliable and innovative tools for respiratory disease management. The company generates revenue through the sale of its diagnostic devices and associated services.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2012
Headquarters: Pleasanton, United States
Employees: 1
Open positions: None listed
Dealroom signal: 58.3/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Non-Invasive medical devices and treatments, Spinout, DT and LS, science-based
Technology: Deep Tech, Recognition Technology
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITION✓Exit	Jun 2020	$0	—	Caire	—
SERIES C✓Equity / VC	Jan 2018	$15M	$60M	NGK SPARK PLUG CO	—

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Spirosure website traffic

Latest recorded traffic for Spirosure is 120 monthly website visits, down 60% over the last three months. Spirosure's team grew 0% over the past year.

Latest monthly visits120 3-month web change-60% 1-year team growth0%

Monthly website visitsOct 2017–Apr 2024

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
GCGalil Medical, a BTG International group companyGalil Medical \| Cryotherapy Solutions \| Ablation of solid tumor cancers \| Nerve Ablation for pain management \| Cryoablation \| Cryosurgery	Arden Hills, United States	Operational	—	$52M	—
CMCnsystems medizintechnikCNSystems Medizintechnik sells, manufactures, and develops equipment for non-invasive, continuous monitoring of blood pressure	Graz, Austria	Operational
KRKribaNon-invasive screening and monitoring of serous fluids infections of the body	Madrid, Spain	Operational
NENeuroSyncNeuro-technology with foundational ip in eye-tracking metrics and devices	Palo Alto, United States	Operational
TETendoNovaA medical technology company that provides systems for office-based orthopedic procedures to address tendon injury and pain	Atlanta, United States	Operational
PBPredictive BiosciencesMolecular diagnostics company developing diagnostic products for informed cancer management	Lexington, United States	Operational
FLFlexDexAn innovative medical device company based in Michigan, with a passion for bringing cutting edge technology from an idea into reality	Brighton Township, United States	Operational
LLLeuko LabsDeveloping the first device for non-invasive white cell monitoring	Boston, United States	Operational